Skip to content
← Back to this collection

PUBLICATIONS · 36399695

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Mar 20
First author
Laetsch TW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Mar 20;41(9):1646-1648. doi: 10.1200/JCO.22.02345.
    note
    Source null
    related pmid
    36634289
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2023 May 1;41(13):2450-2451. doi: 10.1200/JCO.22.02839.
    note
    Source null
    related pmid
    36898080
    relationship
    Comment in
  3. citation
    Transl Pediatr. 2023 Oct 30;12(10):1900-1907. doi: 10.21037/tp-23-366.
    note
    Source null
    related pmid
    37969122
    relationship
    Comment in
  4. citation
    Transl Pediatr. 2024 Apr 30;13(4):535-536. doi: 10.21037/tp-23-535.
    note
    Source null
    related pmid
    38715679
    relationship
    Comment in

Authors and identifiers

  1. name
    Laetsch TW
    type
    Author
  2. name
    Maude SL
    type
    Author
  3. name
    Rives S
    type
    Author
  4. name
    Hiramatsu H
    type
    Author
  5. name
    Bittencourt H
    type
    Author
  6. name
    Bader P
    type
    Author
  7. name
    Baruchel A
    type
    Author
  8. name
    Boyer M
    type
    Author
  9. name
    De Moerloose B
    type
    Author
  10. name
    Qayed M
    type
    Author
  11. name
    Buechner J
    type
    Author
  12. name
    Pulsipher MA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Laetsch TW
    type
    Author
  2. name
    Maude SL
    type
    Author
  3. name
    Rives S
    type
    Author
  4. name
    Hiramatsu H
    type
    Author
  5. name
    Bittencourt H
    type
    Author
  6. name
    Bader P
    type
    Author
  7. name
    Baruchel A
    type
    Author
  8. name
    Boyer M
    type
    Author
  9. name
    De Moerloose B
    type
    Author
  10. name
    Qayed M
    type
    Author
  11. name
    Buechner J
    type
    Author
  12. name
    Pulsipher MA
    type
    Author
bibliography ids
  1. nci-bib-fcb0d3658af60940cb49e2d0
book metadata
content sha256
6b1bfd4291165fa277aad045cc107ee4c507a965c94e17377da4e68cdcff0b4a
document type
citation
dois
  1. 10.1200/JCO.22.00642
electronic publication date
display
2022 Nov 18
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36399695
immutable id
pubmed:36399695@6b1bfd4291165fa277aad045cc107ee4c507a965c94e17377da4e68cdcff0b4a
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
9
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1664-1669
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Mar 20;41(9):1646-1648. doi: 10.1200/JCO.22.02345.
    note
    Source null
    related pmid
    36634289
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2023 May 1;41(13):2450-2451. doi: 10.1200/JCO.22.02839.
    note
    Source null
    related pmid
    36898080
    relationship
    Comment in
  3. citation
    Transl Pediatr. 2023 Oct 30;12(10):1900-1907. doi: 10.21037/tp-23-366.
    note
    Source null
    related pmid
    37969122
    relationship
    Comment in
  4. citation
    Transl Pediatr. 2024 Apr 30;13(4):535-536. doi: 10.21037/tp-23-535.
    note
    Source null
    related pmid
    38715679
    relationship
    Comment in
outcomes validated
false
pmid
36399695
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
450fbf70c0ecef616209e793a447f0247dc93ba929341bc5a8bb86ff972748af
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Mar 20
precision
day
year
2023
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36399695/
title
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.

Preserved source evidence · Not medical advice